flumazenil has been researched along with 17-alpha-hydroxypregnenolone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaujean, D; Do-Rego, JL; Leprince, J; Luu-The, V; Mensah-Nyagan, AG; Pelletier, G; Tonon, MC; Vaudry, H | 1 |
do Rego, JL; Vaudry, D; Vaudry, H | 1 |
2 other study(ies) available for flumazenil and 17-alpha-hydroxypregnenolone
Article | Year |
---|---|
The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Animals; Carbolines; Chromatography, High Pressure Liquid; Dehydroepiandrosterone; Diazepam Binding Inhibitor; Dihydrotestosterone; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hydroxysteroids; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Ligands; Male; Neuroglia; Neurons; Neuropeptides; Peptide Fragments; Pregnenolone; Progesterone; Rana ridibunda; Receptors, GABA-A | 2001 |
The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.
Topics: 17-alpha-Hydroxypregnenolone; 20-alpha-Dihydroprogesterone; Animals; Anti-Anxiety Agents; Bicuculline; Complex Mixtures; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Gene Expression; Hypothalamus; Isoquinolines; Male; Neuropeptides; Oxazines; Peptide Fragments; Pregnanolone; Progesterone; Rana esculenta; Receptors, GABA-A; Tissue Culture Techniques | 2015 |